39.85
price up icon2.21%   0.86
after-market Dopo l'orario di chiusura: 39.53 -0.32 -0.80%
loading
Precedente Chiudi:
$38.99
Aprire:
$38.44
Volume 24 ore:
5,604
Relative Volume:
0.21
Capitalizzazione di mercato:
$2.60B
Reddito:
$136.33M
Utile/perdita netta:
$-56.34M
Rapporto P/E:
-53.11
EPS:
-0.7504
Flusso di cassa netto:
$-18.87M
1 W Prestazione:
-0.35%
1M Prestazione:
+58.01%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$38.44
$39.85
Intervallo di 1 settimana:
Value
$37.00
$40.81
Portata 52W:
Value
$17.09
$40.81

Ascentage Pharma Group International Adr Stock (AAPG) Company Profile

Name
Nome
Ascentage Pharma Group International Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
567
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
AAPG's Discussions on Twitter

Confronta AAPG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AAPG
Ascentage Pharma Group International Adr
39.85 2.60B 136.33M -56.34M -18.87M -0.7504
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Ascentage Pharma Group International Adr Stock (AAPG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-27 Iniziato JP Morgan Overweight

Ascentage Pharma Group International Adr Borsa (AAPG) Ultime notizie

pulisher
Jun 15, 2025

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 10, 2025

Ascentage Pharma’s Studies to be Featured at 2025 EHA Congress - TipRanks

Jun 10, 2025
pulisher
Jun 09, 2025

Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress - marketscreener.com

Jun 09, 2025
pulisher
Jun 03, 2025

Ascentage Pharma Unveils Promising Data on Alrizomadlin at ASCO 2025 - TipRanks

Jun 03, 2025
pulisher
May 20, 2025

Ascentage Pharma Announces Successful AGM Resolutions on May 19, 2025 - TipRanks

May 20, 2025
pulisher
May 13, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV), Xencor (XNCR) and Intellia Therapeutics (NTLA) - The Globe and Mail

May 13, 2025
pulisher
Apr 17, 2025

Ascentage Pharma Files Annual Report, Announces Shareholder Meeting By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Ascentage Pharma Files Annual Report, Announces Shareholder Meeting - Investing.com

Apr 17, 2025
pulisher
Mar 27, 2025

JPMorgan sets Ascentage Pharma stock to Overweight, $27 target - Investing.com

Mar 27, 2025
pulisher
Mar 14, 2025

Takeda Pharmaceutical Company (TKPYY) Stock: Strategic Focus on Oncology and Growth Opportunities - Value the Markets

Mar 14, 2025
pulisher
Mar 12, 2025

Ascentage Pharma to Announce 2024 Financial Results and Corporate Update - TipRanks

Mar 12, 2025
pulisher
Jan 27, 2025

Avoid the Trap: 3 High-yield Dividend Stocks With Safe Payouts - The Globe and Mail

Jan 27, 2025
pulisher
Jan 24, 2025

Ascentage Pharma IPO opens flat - Investing.com

Jan 24, 2025
pulisher
Jan 24, 2025

Ascentage Pharma shares slide ahead of ADS debut on Nasdaq - Investing.com

Jan 24, 2025
pulisher
Jan 23, 2025

Ascentage prices first biotech IPO of 2025, raising $126M - BioPharma Dive

Jan 23, 2025
pulisher
Jan 22, 2025

Ascentage Pharma sets terms for $149 million US IPO - The Pharma Letter

Jan 22, 2025
pulisher
Dec 30, 2024

Takeda-backed Ascentage Pharma files for $100M IPO (IPO:NYSEARCA) - Seeking Alpha

Dec 30, 2024
pulisher
Nov 18, 2024

Market Capitalization: What It Is, Formula for Calculating It - Investopedia

Nov 18, 2024
pulisher
Jun 24, 2024

Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares - PR Newswire

Jun 24, 2024
pulisher
Jun 14, 2024

Takeda, Ascentage Pharma Sign Option Agreement - Contract Pharma

Jun 14, 2024
pulisher
Feb 13, 2024

BIIB Stock Quote Price and Forecast - CNN

Feb 13, 2024
pulisher
Nov 06, 2019

Capital Markets - Wilson Sonsini

Nov 06, 2019
pulisher
Oct 13, 2012

Morningstar | Empowering Investor Success - Morningstar

Oct 13, 2012
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN Logo

Jul 27, 2011

Ascentage Pharma Group International Adr Azioni (AAPG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):